Literature DB >> 19745821

Effects of 17-hydroxyprogesterone on tumor necrosis factor-alpha-induced hypertension during pregnancy.

Sharon D Keiser1, Edward W Veillon, Marc R Parrish, William Bennett, Kathy Cockrell, Lillian Fournier, Joey P Granger, James N Martin, Babbette Lamarca.   

Abstract

BACKGROUND: Inflammatory cytokines such as tumor necrosis factor-alpha (TNF-alpha) may be an important link between placental ischemia and hypertension in preeclampsia. We examined the effect of 17-hydroxyprogesterone caproate (17-OHP) on TNF-alpha-stimulated endothelin (ET) production and hypertension during pregnancy.
METHODS: TNF-alpha-stimulated ET was examined from endothelial cells cultured in the presence and absence of progesterone. Blood pressure and tissue ET-1 were measured in the following groups of pregnant rats: controls, 17-OHP (3.32 mg/kg), TNF-alpha treated (50 ng/day), TNF-alpha treated+17-OHP.
RESULTS: Progesterone abolished TNF-alpha-stimulated ET-1 from endothelial cells. TNF-alpha-induced hypertension was associated with significant increases in renal and placental ET-1. Administration of 17-OHP attenuated TNF-alpha-induced hypertension and decreased renal ET-1.
CONCLUSION: Progesterone directly abolished TNF-alpha-stimulated ET-1 and attenuated TNF-alpha-induced hypertension, possibly via suppression of the renal ET-1 system. These data suggest that treatment with progesterone of hypertension associated with elevated cytokines during pregnancy may be worthy of further consideration.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19745821      PMCID: PMC2810643          DOI: 10.1038/ajh.2009.149

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  23 in total

Review 1.  Recent progress toward the understanding of the pathophysiology of hypertension during preeclampsia.

Authors:  Babbette D LaMarca; Jeffery Gilbert; Joey P Granger
Journal:  Hypertension       Date:  2008-02-07       Impact factor: 10.190

2.  Transcriptional regulation of the endothelin-1 gene by TNF-alpha.

Authors:  P A Marsden; B M Brenner
Journal:  Am J Physiol       Date:  1992-04

3.  Time course of maternal plasma volume and hormonal changes in women with preeclampsia or fetal growth restriction.

Authors:  Sofía P Salas; Guillermo Marshall; Blanca L Gutiérrez; Pedro Rosso
Journal:  Hypertension       Date:  2005-12-27       Impact factor: 10.190

Review 4.  Placental cytokines and the pathogenesis of preeclampsia.

Authors:  K P Conrad; D F Benyo
Journal:  Am J Reprod Immunol       Date:  1997-03       Impact factor: 3.886

Review 5.  Prevention and treatment of pregnancy-induced hypertension (preeclampsia) with progestogens.

Authors:  M B Sammour; H el-Kabarity; M M Fawzy; A E Schindler
Journal:  J Steroid Biochem Mol Biol       Date:  2005-10-19       Impact factor: 4.292

Review 6.  Preeclampsia: recent insights.

Authors:  James M Roberts; Hilary S Gammill
Journal:  Hypertension       Date:  2005-10-17       Impact factor: 10.190

7.  Endothelin excretion in hypertensive pregnancy. Relationship to glomerular filtration rate, blood pressure, and sodium excretion.

Authors:  M X Wang; M A Brown; M L Buddle; M A Carlton; G M Cario; J A Whitworth
Journal:  Am J Hypertens       Date:  1994-04       Impact factor: 2.689

8.  Autoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor alpha in pregnant rats.

Authors:  Babbette LaMarca; Gerd Wallukat; Mayte Llinas; Florian Herse; Ralf Dechend; Joey P Granger
Journal:  Hypertension       Date:  2008-10-13       Impact factor: 10.190

9.  Hypertension in response to chronic reductions in uterine perfusion in pregnant rats: effect of tumor necrosis factor-alpha blockade.

Authors:  Babbette LaMarca; Josh Speed; Lillian Fournier; Sara A Babcock; Hunter Berry; Kathy Cockrell; Joey P Granger
Journal:  Hypertension       Date:  2008-11-03       Impact factor: 10.190

10.  Maternal plasma level of endothelin is increased in preeclampsia.

Authors:  A Nova; B M Sibai; J R Barton; B M Mercer; M D Mitchell
Journal:  Am J Obstet Gynecol       Date:  1991-09       Impact factor: 8.661

View more
  19 in total

1.  17-hydroxyprogesterone caproate significantly improves clinical characteristics of preeclampsia in the reduced uterine perfusion pressure rat model.

Authors:  Lorena M Amaral; Denise C Cornelius; Ashlyn Harmon; Janae Moseley; James N Martin; Babbette LaMarca
Journal:  Hypertension       Date:  2014-11-03       Impact factor: 10.190

2.  Endothelial dysfunction. An important mediator in the pathophysiology of hypertension during pre-eclampsia.

Authors:  B Lamarca
Journal:  Minerva Ginecol       Date:  2012-08

3.  The role of immune activation in contributing to vascular dysfunction and the pathophysiology of hypertension during preeclampsia.

Authors:  B Lamarca
Journal:  Minerva Ginecol       Date:  2010-04

Review 4.  Elucidating immune mechanisms causing hypertension during pregnancy.

Authors:  Babbette LaMarca; Denise Cornelius; Kedra Wallace
Journal:  Physiology (Bethesda)       Date:  2013-07

5.  Continued Investigation Into 17-OHPC: Results From the Preclinical RUPP Rat Model of Preeclampsia.

Authors:  Lorena M Amaral; Jessica L Faulkner; Jamil Elfarra; Denise C Cornelius; Mark W Cunningham; Tarek Ibrahim; Venkata Ramana Vaka; Jessica McKenzie; Babbette LaMarca
Journal:  Hypertension       Date:  2017-10-30       Impact factor: 10.190

6.  The effect of immune factors, tumor necrosis factor-alpha, and agonistic autoantibodies to the angiotensin II type I receptor on soluble fms-like tyrosine-1 and soluble endoglin production in response to hypertension during pregnancy.

Authors:  Marc R Parrish; Sydney R Murphy; Sarah Rutland; Kedra Wallace; Katrin Wenzel; Gerd Wallukat; Sharon Keiser; Lillian Fournier Ray; Ralf Dechend; James N Martin; Joey P Granger; Babbette LaMarca
Journal:  Am J Hypertens       Date:  2010-04-29       Impact factor: 2.689

7.  Progesterone blunts vascular endothelial cell secretion of endothelin-1 in response to placental ischemia.

Authors:  Luissa V Kiprono; Kedra Wallace; Janae Moseley; James Martin; Babbette Lamarca
Journal:  Am J Obstet Gynecol       Date:  2013-03-29       Impact factor: 8.661

8.  17-Hydroxyprogesterone caproate improves T cells and NK cells in response to placental ischemia; new mechanisms of action for an old drug.

Authors:  Jamil T Elfarra; Jesse N Cottrell; Denise C Cornelius; Mark W Cunningham; Jessica L Faulkner; Tarek Ibrahim; Babbette Lamarca; Lorena M Amaral
Journal:  Pregnancy Hypertens       Date:  2019-12-02       Impact factor: 2.899

9.  Mechanism of the protective effects of the combined treatment with rhynchophylla total alkaloids and sinapine thiocyanate against a prothrombotic state caused by vascular endothelial cell inflammatory damage.

Authors:  Yunlun Li; Xinya Zhang; Wenqing Yang; Chao Li; Yanjun Chu; Haiqiang Jiang; Zhenzhen Shen
Journal:  Exp Ther Med       Date:  2017-04-18       Impact factor: 2.447

Review 10.  Identifying immune mechanisms mediating the hypertension during preeclampsia.

Authors:  Babbette LaMarca; Denise C Cornelius; Ashlyn C Harmon; Lorena M Amaral; Mark W Cunningham; Jessica L Faulkner; Kedra Wallace
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-04-20       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.